Abstract

Body fat distribution is a major, heritable risk factor for cardiometabolic disease, independent of overall adiposity. Using exome-sequencing in 618,375 individuals (including 160,058 non-Europeans) from the UK, Sweden and Mexico, we identify 16 genes associated with fat distribution at exome-wide significance. We show 6-fold larger effect for fat-distribution associated rare coding variants compared with fine-mapped common alleles, enrichment for genes expressed in adipose tissue and causal genes for partial lipodystrophies, and evidence of sex-dimorphism. We describe an association with favorable fat distribution (p = 1.8 × 10−09), favorable metabolic profile and protection from type 2 diabetes (~28% lower odds; p = 0.004) for heterozygous protein-truncating mutations in INHBE, which encodes a circulating growth factor of the activin family, highly and specifically expressed in hepatocytes. Our results suggest that inhibin βE is a liver-expressed negative regulator of adipose storage whose blockade may be beneficial in fat distribution-associated metabolic disease.

Fat distribution is associated with cardiometabolic disease, although it has been less well studied than overall obesity. In a multiancestry exome-sequencing study, the authors identified predicted loss-of-function mutations in INHBE associated with favorable fat distribution and protection from type 2 diabetes.

Details

Title
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes
Author
Akbari, Parsa 1 ; Sosina, Olukayode A. 1   VIAFID ORCID Logo  ; Bovijn, Jonas 1 ; Landheer, Karl 2   VIAFID ORCID Logo  ; Nielsen, Jonas B. 1 ; Kim, Minhee 1 ; Aykul, Senem 1   VIAFID ORCID Logo  ; De, Tanima 1 ; Haas, Mary E. 1   VIAFID ORCID Logo  ; Hindy, George 1 ; Lin, Nan 1 ; Dinsmore, Ian R. 3 ; Luo, Jonathan Z. 3 ; Hectors, Stefanie 2 ; Geraghty, Benjamin 1 ; Germino, Mary 2 ; Panagis, Lampros 2 ; Parasoglou, Prodromos 2 ; Walls, Johnathon R. 2 ; Halasz, Gabor 2 ; Atwal, Gurinder S. 2 ; Della Gatta, Giusy 1 ; Jones, Marcus 1 ; LeBlanc, Michelle G. 1 ; Still, Christopher D. 4 ; Carey, David J. 4 ; Giontella, Alice 5 ; Orho-Melander, Marju 6   VIAFID ORCID Logo  ; Berumen, Jaime 7   VIAFID ORCID Logo  ; Kuri-Morales, Pablo 8 ; Alegre-Díaz, Jesus 7   VIAFID ORCID Logo  ; Torres, Jason M. 9 ; Emberson, Jonathan R. 9   VIAFID ORCID Logo  ; Collins, Rory 10 ; Rader, Daniel J. 11   VIAFID ORCID Logo  ; Zambrowicz, Brian 2   VIAFID ORCID Logo  ; Murphy, Andrew J. 2   VIAFID ORCID Logo  ; Balasubramanian, Suganthi 1 ; Overton, John D. 1 ; Reid, Jeffrey G. 1   VIAFID ORCID Logo  ; Shuldiner, Alan R. 1   VIAFID ORCID Logo  ; Cantor, Michael 1 ; Abecasis, Goncalo R. 1   VIAFID ORCID Logo  ; Ferreira, Manuel A. R. 1   VIAFID ORCID Logo  ; Sleeman, Mark W. 2 ; Gusarova, Viktoria 2 ; Altarejos, Judith 2 ; Harris, Charles 2 ; Economides, Aris N. 12   VIAFID ORCID Logo  ; Idone, Vincent 2 ; Karalis, Katia 1 ; Mirshahi, Tooraj 4   VIAFID ORCID Logo  ; Yancopoulos, George D. 2 ; Melander, Olle 13 ; Marchini, Jonathan 1   VIAFID ORCID Logo  ; Tapia-Conyer, Roberto 14   VIAFID ORCID Logo  ; Locke, Adam E. 1   VIAFID ORCID Logo  ; Baras, Aris 1   VIAFID ORCID Logo  ; Verweij, Niek 1 ; Lotta, Luca A. 1   VIAFID ORCID Logo 

 Regeneron Pharmaceuticals Inc, Regeneron Genetics Center, Tarrytown, USA (GRID:grid.418961.3) (ISNI:0000 0004 0472 2713) 
 Regeneron Pharmaceuticals Inc, Tarrytown, USA (GRID:grid.418961.3) (ISNI:0000 0004 0472 2713) 
 Geisinger Health System, Department of Molecular and Functional Genomics, Danville, USA (GRID:grid.280776.c) (ISNI:0000 0004 0394 1447) 
 Geisinger Health System, Geisinger Obesity Institute, Danville, USA (GRID:grid.280776.c) (ISNI:0000 0004 0394 1447) 
 Lund University, Department of Clinical Sciences Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); University of Verona, Department of Medicine, Verona, Italy (GRID:grid.5611.3) (ISNI:0000 0004 1763 1124) 
 Lund University, Department of Clinical Sciences Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Unidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autónoma de México, Mexico City, Mexico (GRID:grid.9486.3) (ISNI:0000 0001 2159 0001) 
 Unidad de Medicina Experimental de la Facultad de Medicina de la Universidad Nacional Autónoma de México, Mexico City, Mexico (GRID:grid.9486.3) (ISNI:0000 0001 2159 0001); Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701) 
 University of Oxford, MRC Population Health Research Unit, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Clinical Trial Service Unit & Epidemiological Studies Unit Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
10  University of Oxford, Clinical Trial Service Unit & Epidemiological Studies Unit Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
11  University of Pennsylvania, Department of Genetics, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
12  Regeneron Pharmaceuticals Inc, Regeneron Genetics Center, Tarrytown, USA (GRID:grid.418961.3) (ISNI:0000 0004 0472 2713); Regeneron Pharmaceuticals Inc, Tarrytown, USA (GRID:grid.418961.3) (ISNI:0000 0004 0472 2713) 
13  Lund University, Department of Clinical Sciences Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Skåne University Hospital, Department of Emergency and Internal Medicine, Malmö, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987) 
14  Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2705553818
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.